CD19 from ACROBiosystems

CD19 Molecule Information

Name:B-lymphocyte antigen CD19
Target Synonym:CD19?T-cell surface antigen Leu-12?B-lymphocyte surface antigen B4?B-lymphocyte antigen CD19?Differentiation antigen CD19?CD_antigen=CD19
Number of Launched Drugs:3
Number of Drugs in Clinical Trials:75
Lastest Research Phase:Approved

CD19 Molecule Synonym Name

CD19, B4, CVID3, MGC12802

CD19 Molecule Background

B-lymphocyte antigen CD19 (CD19) is also known as B-lymphocyte surface antigen B4, Differentiation antigen CD19 and T-cell surface antigen Leu-12, which is a single-pass type I  membrane protein and contains two Ig-like C2-type (immunoglobulin-like) domains.

CD19 forms a complex with CD21, CD81 and CD225 in the membrane of mature B cells. CD19 interacts with GRB2 and SOS when phosphorylated on Tyr-348 and/or Tyr-378. CD19 also interacts with PLCG2 when phosphorylated on Tyr-409. CD19 is an important pan B cell marker and co-stimulatory protein in humans and mice.

CD19 is a hallmark differentiation antigen of the B cell lineage and positively regulates antigen receptor signal transduction in mature B cells. CD19 defines signaling thresholds for the Ag receptor as well as other cell surface receptors that regulate B lymphocyte selection, activation, and differentiation. Defects in CD19 are a cause of hypogammaglobulinemia.